Guardian Pharmacy Services (NYSE:GRDN) Trading Up 5.4% – Here’s Why

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) shot up 5.4% during trading on Tuesday . The company traded as high as $39.34 and last traded at $39.11. Approximately 328,979 shares were traded during mid-day trading, a decline of 15% from the average session volume of 386,244 shares. The stock had previously closed at $37.09.

Analyst Ratings Changes

Several equities analysts have recently issued reports on GRDN shares. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Finally, Oppenheimer boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Price Performance

The company’s 50-day moving average price is $39.80 and its two-hundred day moving average price is $38.01. The company has a market capitalization of $1.96 billion, a P/E ratio of 38.19, a price-to-earnings-growth ratio of 2.01 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The company had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. On average, analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

Several hedge funds have recently bought and sold shares of GRDN. Ameritas Investment Partners Inc. grew its holdings in shares of Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after acquiring an additional 345 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth about $43,000. State of Wyoming bought a new stake in shares of Guardian Pharmacy Services in the 2nd quarter valued at about $58,000. Strs Ohio bought a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $75,000. Finally, Clearstead Advisors LLC raised its stake in Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after buying an additional 1,741 shares in the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.